Evaluating surrogate markers of clinical outcome when measured with error

Biometrics

Volumn 54, Issue 4, 1998, Pages 1445-1462

  Dafni, Urania G ^a   Tsiatis, Anastasios A ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

AIDS; Measurement error; Proportional hazards; Surrogate markers; Time varying covariates

Indexed keywords

HAZARDS; MEDICAL APPLICATIONS;

AIDS; BIASED ESTIMATES; CLINICAL OUTCOME; CLINICAL TRIAL; COVARIATES; COX MODEL; PROPORTIONAL HAZARDS; SURROGATE MARKER; TIME VARYING; TIME VARYING COVARIATE;

MEASUREMENT ERRORS;

ANTIVIRUS AGENT; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL; SURVIVAL RATE; TREATMENT OUTCOME; VIRUS INFECTION;

EID: 0032433456     PISSN: 0006341X     EISSN: None     Source Type: Journal    
DOI: 10.2307/2533670     Document Type: Article

References (19)

1. Breslow, N. (1974). Covariance analysis of censored survival data. Biometrics 30, 89-99.
2. Carroll, R. J., Ruppert, D., and Stefanski, L. A. (1995). Measurement Error in Nonlinear Models. London: Chapman and Hall.
3. Choi, S., Lagakos, S. W., Schooley, R., and Volberding, P. (1993). CD4 lymphocytes are incomplete surrogate markers for clinical progression in persons with asymptomatic HIV infection taking Zidovudine. Annals of Internal Medicine 118, 674-680.
4. Cox, D. R. (1972). Regression models and life tables. Journal of the Royal Statistical Society, Series B 34, 187-220.
5. Cox, D. R. (1975). Partial likelihood. Biometrika 62, 269-276.
6. DeGruttola, V., Lange, N., and Dafni, U. (1991). Modeling the progression of HIV infection. Journal of the American Statistical Association 86, 569-577.
7. Fischl, M. A., Richman, D. D., Hansen, N., et al. (1990). The safety and efficacy of Zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. Annals of Internal Medicine 112, 727-737.
8. Guttman, I. (1982). Linear Models. New York: Wiley.
9. Hughes, M. D. (1993). Regression dilution in the proportional hazards model. Biometrics 49, 1056-1066.
10. Jones, R. H. and Ackerson, L. M. (1990). Serial correlation in unequally spaced longitudinal data. Biometrika 77, 721-731.
11. Lagakos, S. W. and Hoth, D. F. (1992). Surrogate markers in AIDS: Where are we? Where are we going? Annals of Internal Medicine 116, 599-601.
12. Laird, N. M. and Ware, J. H. (1982). Random-effects models for longitudinal data. Biometrics 38, 963-974.
13. Pepe, M. S., Self, G. S., and Prentice, R. L. (1989). Further results on covariate measurement errors in cohort studies with time response data. Statistics in Medicine 8, 1167-1178.
14. Prentice, R. L. (1982). Covariate measurement errors and parameter estimation in a failure time regression model. Biometrika 69, 331-342.
15. Prentice, R. L. (1989). Surrogate endpoints in clinical trials: Definition and operational criteria. Statistics in Medicine 8, 431-440.
16. Prentice, R. L. and Self, S. G. (1983). Asymptotic distribution theory for Cox-type regression models with general relative risk form. The Annals of Statistics 11, 804-813.
17. Tsiatis, A. A., Dafni, U., DeGruttola, V., Propert, K. J., Strawderman, R. L., and Wulfsohn, M. (1992). The relationship of CD4 counts over time to survival in patients with AIDS: Is CD4 a good surrogate marker? In AIDS Epidemiology: Methodological Issues, N. Jewell, K. Dietz, and V. Farewell (eds), 256-274. Boston: Birkhauser.
18. Tsiatis, A. A., DeGruttola, V., and Wulfsohn, M. (1995). Modeling the relationship of survival to longitudinal data measured with error: Applications to survival and CD4 counts in patients with AIDS. Journal of the American Statistical Association 90, 27-37.
19. Vittinghoff, E., Malani, H. M., and Jewell, N. P. (1994). Estimating patterns of CD4 lymphocyte decline using data from a prevalent cohort of HIV infected individuals. Statistics in Medicine 13, 1101-1118.